DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Amrinone
Amrinone
NINDS Custom Collection II
Order in Council 1243/1995
Identification of Cancer Cytotoxic Modulators of PDE3A by Predictive Chemogenomics
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
1 Elevated Intracellular Camp Concentration Mediates Growth
(12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
Calcium and Heart Failure: How Did We Get Here and Where Are We Going?
2021 Equine Prohibited Substances List
(12) United States Patent (10) Patent No.: US 9,456,997 B2 Stauffer Et Al
Elevated Intracellular Camp Concentration Mediates Growth Suppression in Glioma Cells
Theranostics PDE Inhibition in Distinct Cell Types to Reclaim the Balance Of
(12) Patent Application Publication (10) Pub. No.: US 2009/0005327 A1 GRANATA Et Al
Inhibitors of Phosphodiesterase Isoforms III Or IV Suppress Islet-Cell Nitric Oxide Production Evette Beshay and Gérald J
Inotropic Drugs and Their Mechanisms of Action
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
The University of Chicago Microbially-Regulated
Top View
(PDE) Isoenzymes As Pharmacologic Targets in Urology: Present and Future
Customs Tariff - Schedule
Agent, Vesnarinone
Drug Schedules Regulation B.C
Customs Tariff - Schedule Xxi - 1
A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
KENTUCKY HORSE RACING Chapter: \810\008.020REG
Pharmaceutical Appendix to the Tariff Schedule 2
New Positive Inotropic Agents
Elevated Intracellular Camp Concentration Mediates Growth Suppression in Glioma Cells
Harmonized Tariff Schedule of the United States (2006) (Rev
Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
Neurogenesis Via Modulation of the Muscarinic Receptors
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Comparison of the Cardiovascular Effects of Intracellular Cyclic Adenosine 3’,5’- Monophosphate (Camp)-Modulating Agents in Isoflurane-Anesthetized Cats
Pharmaceutical Appendix to the Tariff Schedule 2
Inotropes Are Not Linked to Increased Mortality in Heart Failure
PDE3 Inhibitors Repurposed As Treatments for Age-Related Cognitive Impairment
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(19) United States (12) Patent Application Publication (10) Pub
Pharmacological Potential of PDE5 Inhibitors for the Treatment of Cystic Fibrosis
Reassessment of Dobutamine, Dopamine, and Milrinone in the Management of Acute Heart Failure Syndromes
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving